Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results67% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (7)
Early P 1 (2)
P 2 (1)
P 4 (1)

Trial Status

Completed4
Unknown3
Terminated2
Not Yet Recruiting1
Recruiting1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (11)

Research Network

Activity Timeline